What sector does Anuh Pharma Limited belong to?

Anuh Pharma Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of ANUHPHR?

As of the latest available quote, ANUHPHR traded at ₹94.86. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of ANUHPHR?

Anuh Pharma Limited has a price-to-earnings (P/E) ratio of about 26.50. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of ANUHPHR?

The market capitalisation of Anuh Pharma Limited is approximately ₹951 Cr.

Is Anuh Pharma Limited profitable?

For its latest reported financial year, Anuh Pharma Limited recorded a net profit margin of about 5.31%.

Does ANUHPHR pay a dividend?

Anuh Pharma Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of ANUHPHR?

Anuh Pharma Limited has a return on equity (ROE) of about 10.70%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of ANUHPHR?

Over the past 52 weeks, ANUHPHR has traded between a low of ₹67.00 and a high of ₹99.50.

Anuh Pharma Limited

ANUHPHR NSE Healthcare Pharmaceuticals

₹94.86

+4.00%

Delayed · cached 15 min

Fair value analysis

ANUHPHR

Anuh Pharma Limited

₹91.21

Close used for this calculation

₹81.72Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

35/100

Profitability11/25

Returns10/25

Balance Sheet3/25

Efficiency11/25

Growth4/25

Average

Quality radar

Consensus fair value

₹81.72

Near FV

▼ -10.4% against the close used

Model range ₹17.63 – ₹146.37

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹17.63Fair value₹81.72Bull₹146.37

FairClose

52-week traded range

52W low ₹67.0052W high ₹96.74

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Anuh Pharma Limited closed at ₹91.21, 11.6% above the consensus fair value of ₹81.72 drawn from 10 valuation models.

Financial DNA score 35/100 — Average. P/E of 21.5x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹62.11

-31.9%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=4.3%, r=10%, tg=3%, n=10yr

Graham Number

₹57.90

-36.5%

√(22.5 × EPS × BVPS)

EPS=4.1, BVPS=36.34 · outside Graham range (P/E 21.5, P/B 2.5) — asset-light, treat as a rough floor

Graham Formula

₹65.10

-28.6%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=4.3%, FD=7%

P/E Fair Value

₹146.37

+60.5%

EPS × 35.7x (sector P/E)

EPS=4.1, Sector P/E=35.7x

Peter Lynch (PEG)

₹17.63

-80.7%

EPS × Growth% (PEG = 1 is fair)

EPS=4.1, g=4.3%

EV/EBITDA

₹85.07

-6.7%

(EBITDA × 12.2x − Net Debt) ÷ Shares

EBITDA=730M

Dividend Discount (DDM)

₹26.37

-71.1%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=1.44, r=10%, g=4.3%

Book Value (P/B)

₹40.80

-55.3%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=36.34, ROE=10.7%, g=4.3%, r=10%

Reverse DCF

₹91.21

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 8.6% | Historical: 4.3%

Margin of Safety

₹62.15

-31.9%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=82.87, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer